Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;355(11):e2200208.
doi: 10.1002/ardp.202200208. Epub 2022 Jul 25.

Aminoalkoxy-substituted coumarins: Synthesis and evaluation for reactivation of inhibited human acetylcholinesterase

Affiliations

Aminoalkoxy-substituted coumarins: Synthesis and evaluation for reactivation of inhibited human acetylcholinesterase

Paul W Elsinghorst et al. Arch Pharm (Weinheim). 2022 Nov.

Abstract

Reactivation of inhibited acetylcholinesterase remains an important therapeutic strategy for the treatment of poisoning by organophosphorus compounds, such as nerve agents or pesticides. Although drugs like obidoxime or pralidoxime have been used with considerable success, there is a need for new substances capable of reactivating acetylcholinesterase with a broader scope and increased efficacy. Possible screening candidates must fulfill two fundamental requirements: They must (i) show an affinity to acetylcholinesterase well balanced between sufficient binding and competitive inhibition and (ii) facilitate the nucleophilic cleavage of the phosphorylated catalytic serine residue. We attached a variety of nonaromatic primary and secondary amines to a coumarin core through selected alkoxy side linkers attached at coumarin positions 6 or 7 to obtain a small set of possible reactivators. Evaluation of their inhibition and reactivation potential in vitro showed some activity with respect to acetylcholinesterase inhibited by cyclosarin.

Keywords: Mitsunobu reaction; acetylcholinesterase; coumarins; enzyme reactivation; organophosphorus compounds.

PubMed Disclaimer

References

REFERENCES

    1. H. John, van der M. J. Schans, M. Koller, H. E. T. Spruit, F. Worek, H. Thiermann, D. Noort, Forensic Toxicol. 2018, 36, 61. https://doi.org/10.1007/s11419-017-0376-7
    1. T. Nakagawa, A. T. Tu, Forensic Toxicol. 2018, 36, 542. https://doi.org/10.1007/s11419-018-0426-9
    1. P. R. Chai, B. D. Hayes, T. B. Erickson, E. W. Boyer, Toxicol. Commun. 2018, 2, 45. https://doi.org/10.1080/24734306.2018.1475151
    1. E. J. Mew, P. Padmanathan, F. Konradsen, M. Eddleston, S. Chang, M. R. Phillips, D. Gunnell, J. Affect. Disord. 2017, 219, 93. https://doi.org/10.1016/j.jad.2017.05.002
    1. N. Amend, K. V. Niessen, T. Seeger, T. Wille, F. Worek, H. Thiermann, Ann. N. Y. Acad. Sci. 2020, 1479, 13. https://doi.org/10.1111/nyas.14336

MeSH terms

Grants and funding